University of Nebraska — Omaha, Nebraska

University of Nebraska is a clinical research site located in Omaha, Nebraska, United States 68198.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Nebraska has participated in 87 clinical trials with 19 currently active.

Therapeutic areas: Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma.

Sponsors: Dana-Farber Cancer Institute, Abiomed Inc., Autolus Limited.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Nebraska?

University of Nebraska has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Nebraska conducted?

University of Nebraska has 87 clinical trials on record, with 19 currently active. Their work covers Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma.

Is University of Nebraska accredited by Crixeo Health?

Yes — University of Nebraska holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Nebraska?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.